Cross-linking in soft capsules, causes and solutions

INTRODUCTION OF SOFT GELATINE CAPSULE

Soft gelatin capsules are a widely used solid dosage form, consisting of two main components:

• Capsule Shell: Primarily made of gelatin, plasticizers (e.g., glycerin or sorbitol), an appropriate solvent (usually water), flavoring agents, and coloring agents.

• Capsule Fill (Liquid or Semisolid Formulation): Depending on the formulation, it may include components to create a hydrophilic (PEG-based) or lipophilic (oil-based) solution, a suspension, or an emulsion system.  

Advantages of Soft Gelatin Capsules:

• Convert liquid or semisolid drugs into a solid form, making them easier to swallow and masking unpleasant tastes.
• More precise and stable dosing than liquid dosage forms, reducing batch-to-batch variability in manufacturing.
• Higher bioavailability of active ingredients compared to tablets and hard capsules.
• High drug-loading capacity, with up to 100% liquid fill.
• Customizable appearance, including various shapes and colors, enhancing branding and marketing value

Disadvantages of Soft Gelatin Capsules:

• Complex manufacturing process, requiring precise control over multiple parameters and operator expertise.
• Strict production conditions, including temperature, humidity, and encapsulation parameters.
• Specialized packaging is needed to maintain stability and storage requirements.
• Challenges in drug stability, as some active ingredients are incompatible with softgel formulations.

Common Issues in Soft Gelatin Capsule Manufacturing:

• Active ingredients sensitive to water may degrade (e.g., ranitidine) or undergo polymorphic changes (e.g., terazosin).
• Highly acidic or basic drugs can cause gelatin hydrolysis and capsule leakage.
• Water-soluble drugs may migrate from the fill into the shell, reducing drug concentration in the capsule fill.
• Moisture transfer from the shell to the fill during storage can lead to shell hardening, affecting disintegration and drug release.
• Inadequate packaging may cause capsules to soften or rupture over time.
• Cross-linking in gelatin shells, leading to reduced solubility and slower drug release

CROSS-LINKING PHENOMENON

Cross-linking is the phenomenon where covalent bonds form between the polypeptide chains of gelatin. It is an irreversible reaction, catalyzed by various chemical factors within the formulation or by external environmental factors.

Cross-linking reduces the solubility of gelatin, decreases its swelling capacity, and increases gel strength, making the gelatin shell harder. This negatively impacts the disintegration of capsules in aqueous and gastric environments, leading to reduced dissolution and a slower release of the active ingredient from the capsule fill.

Factors Causing Cross-linking in Gelatin Capsules:

• Aldehyde and Ketone Groups: These functional groups induce cross-linking by forming covalent bonds between two amino groups within the same or adjacent gelatin chains. The degree of cross-linking is strongly influenced by humidity, with the highest impact observed at 60-70% relative humidity.
• Active Ingredients Containing Carbonyl Groups: Rofecoxib, Nimesulide, and macrolide antibiotics.
• Metal Ions and Other Reactive Compounds: Metal ions, polyol sugars, and compounds containing Peroxide, Epoxide, Benzene, Sulfonic acid, Guanidine hydrochloride
• Environmental and Storage Conditions: High temperature, high humidity, and exposure to light can accelerate cross-linking reactions.

Solutions to Prevent Cross-linking:

• Avoid active ingredients and excipients containing aldehyde, ketone, carbonyl groups, and other cross-linking agents.
• Minimize the presence of metal ions in softgel formulations.
• Ensure appropriate storage conditions, avoiding high temperature, humidity, and light, and use protective packaging.
• Use Succinated Gelatin: Gelatin modified with succinic acid can reduce cross-linking. However, it has high permeability to volatile solvents like ethanol and propylene glycol, making it incompatible with formulations containing these solvents. Additionally, this method is ineffective against metal ion-induced cross-linking.
• Use amino acid-based compounds, with Glycine and Lysine being the most common. These act as competitive agents that react with amino groups in the gelatin chain, typically used at a concentration of 0.2 - 5% of the total solid mass of the capsule shell. Additionally, in this method, esters of carboxylic acids with C4 - C20 carbon chains and 2 - 3 carbonyl groups can also be incorporated into the capsule fill or shell, providing a synergistic effect with amino acids.
• Other Compounds Used in the Gelatin Shell: Carboxylic acids (such as citric acid, succinic acid), semicarbazide, hydroxylamine hydrochloride, piperazide, pyridine, pentamethylene imine, glycerin, p-aminobenzoic acid.
• Use Ammonium Salts: These help reduce polyol sugar-induced cross-linking in gelatin capsules.

Cross-linking in soft gelatin capsules is an undesirable phenomenon that can arise due to various raw material properties and manufacturing conditions. Understanding common causes and implementing preventive strategies can help ensure optimal ingredient selection and production conditions, ultimately improving the stability and bioavailability of softgel formulations.